Medical device cybersecurity best practices focus on patient safety, asset visibility and controlled change. Organisations should maintain an accurate inventory, isolate devices where possible, limit remote maintenance, and patch with clinical oversight. They should monitor for unauthorised configuration changes, validate third-party software, and ensure backup, recovery and vulnerability disclosure processes are defined.
What makes medical device cybersecurity different from ordinary IT hardening?
Medical device security is shaped by clinical safety, long service lives and tightly controlled change. A device can be technically vulnerable yet operationally untouchable if it supports care that cannot be interrupted. That means the best practices are not just about blocking threats, they are about maintaining a safe operating state while reducing exposure across the device lifecycle.
Inventory is the foundation because you cannot protect, segment or patch what you have not identified. In practice, that means knowing what the device is, where it sits, what software it runs, how it connects, and who is allowed to maintain it. Without that baseline, every later control becomes partial and every exception becomes harder to govern.
Isolation and change control matter because many devices are safest when they are treated as constrained endpoints rather than general-purpose systems. Network segmentation, restricted remote access and tightly approved maintenance windows reduce the chance that a single compromise or misconfiguration spreads into clinical operations. For broader guidance on device security expectations, see the Medical Device Security Guide.
How should patching, third-party software and maintenance be handled?
Patching medical devices is rarely a simple IT change ticket. Organisations need clinical oversight because the safest patch is not always the fastest one, and compatibility testing may be required before any update reaches production. When a fix must wait, the compensating controls should be explicit, time-bound and owned, not assumed.
Third-party software adds another layer of risk because device security depends on suppliers, embedded components and support contracts as much as on the hospital itself. Validation should cover supplied binaries, remote support tools, update channels and any software that can alter device behaviour. Where a supplier provides remote service access, scope that access tightly and review it as part of the same control set as the device itself.
Maintenance is safest when it is observable and bounded. Remote sessions should be limited to approved use cases, logged, and disabled when not needed. Devices that cannot support modern controls may still be usable, but then the compensating measures, such as segmentation, tighter monitoring and stricter physical placement, need to be stronger. For healthcare-specific identity and access patterns that often intersect with device maintenance, the Healthcare Identity Security Guide is a useful companion.
How do recovery, disclosure and compromise detection fit into device security?
Medical device security is not complete unless the organisation can recover safely after a fault, vulnerability or suspected compromise. Backup and recovery plans need to reflect the clinical role of the device, including configuration recovery, safe rebuild paths and fallback procedures if a device must be taken out of service. A plan that restores software but not clinical readiness is only half a recovery plan.
Detection matters because unauthorised configuration changes can be an early sign of tampering, unsafe maintenance or active compromise. Monitor for changes to settings, firmware, accounts, service interfaces and network behaviour, especially where the device normally changes infrequently. Security teams should also know what normal looks like for each class of device, because the expected baseline is often more useful than generic alerting.
Vulnerability disclosure is part of operational resilience, not just vendor relations. Organisations should know how they receive notices, who triages them, when they test mitigations, and how they decide whether a device remains safe to use. For connected medical devices that share many of the same exposure patterns as other constrained endpoints, the IoT Security Guide provides a practical reference point.
Risk and Threat Considerations
The main risk is not only that a device can be hacked, but that a vulnerable device can become a patient safety issue, an outage, or a pathway into the wider clinical network. Devices are attractive because they are often long-lived, hard to patch and present in high-trust environments where downtime is costly.
Failure mechanism: Attackers or misconfigured support processes exploit weak segmentation, stale software, exposed remote access or uncontrolled configuration paths to alter device behaviour, preserve access or move laterally into adjacent systems.
Impact: The result can be unsafe device operation, loss of availability, delayed care, data exposure, or broader compromise of systems that support clinical workflows.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
CIS Controls v8 and NIST SP 800-53 Rev 5 set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| CIS Controls v8 | CIS-1 — Inventory and Control of Enterprise Assets | Device security starts with accurate asset visibility and ownership. |
| CIS-4 — Secure Configuration of Enterprise Assets and Software | Medical devices need controlled baseline settings and monitored configuration changes. | |
| CIS-7 — Continuous Vulnerability Management | Patch prioritisation and compensating controls depend on knowing device vulnerabilities. | |
| Recommendation — Maintain a complete, current inventory of medical devices and associated software. Apply and monitor approved secure configurations for each device class. Track vulnerabilities continuously and use compensating controls when patching is delayed. | ||
| NIST SP 800-53 Rev 5 | CM-8 — System Component Inventory | An accurate component inventory is central to device visibility and lifecycle control. |
| CM-2 — Baseline Configuration | Controlled device settings and change management are core to safe medical device operation. | |
| RA-5 — Vulnerability Monitoring and Scanning | Defined vulnerability monitoring supports patching decisions and disclosure handling. | |
| Recommendation — Maintain an inventory of medical devices, firmware and supporting components. Establish and enforce baselines for device configuration and maintenance changes. Monitor device vulnerabilities and track remediation or mitigation decisions. | ||
Practitioner Guidance
What to verify: Confirm that each device class has an owner, an inventory record, a support status, a patch path and an approved recovery method. If any of those are missing, the device is already outside normal governance.
Decision rule: If patching threatens clinical continuity, prioritise compensating controls, testing and documented exception handling before delaying remediation indefinitely. If a device cannot be patched or monitored adequately, treat its placement, access and exposure as the primary control problem.
What good looks like: Clinically critical devices have minimal network reachability, tightly governed maintenance access, clear rollback options and a defined process for responding to vendor advisories, vulnerability disclosures and suspected tampering.
Practitioner takeaway: The best medical device security programmes assume that some devices will remain constrained and imperfect, then compensate with visibility, isolation and disciplined change control instead of hoping the device itself can be hardened like ordinary IT.